Burning Rock Biotech Ltd. (BNR)
29.01
-0.91
(-3.04%)
USD |
NASDAQ |
Feb 20, 16:00
29.00
-0.01
(-0.03%)
After-Hours: 20:00
Burning Rock Biotech EPS Diluted (Quarterly) : -0.2173 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Sinovac Biotech Ltd. | -- |
| CASI Pharmaceuticals, Inc. | -0.6781 |
| Zai Lab Ltd. | -0.3267 |
| WuXi Biologics (Cayman), Inc. | -- |
| Viva Biotech Holdings | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.341M |
| Revenue (Quarterly) | 18.39M |
| Total Expenses (Quarterly) | 20.73M |
| Enterprise Value | 251.40M |
| Gross Profit Margin (Quarterly) | 75.10% |
| Profit Margin (Quarterly) | -12.73% |
| Earnings Yield | -5.54% |
| Normalized Earnings Yield | -4.402 |